S. Cho

发表

Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agents.

Sung Soo Kim, H. Cheon, Sung-Don Yang, 2002, Bioorganic & medicinal chemistry letters.

Protein Tyrosine Phosphatase 1B Inhibitors: Catechols

Sung Soo Kim, H. Cheon, Sung-Don Yang, 2003 .

Synthesis and SAR of Benzimidazole Derivatives Containing Oxycyclic Pyridine as a Gastric H+/K+‐ATPase Inhibitors.

H. Cheon, S. Kang, Sungsoo S. Kim, 2002 .

The spectroscopic analysis of γ-irradiated glass by colorimetry, ESR and XPS

H. Park, W. Whiteside, Sung-In Hong, 2008 .

A novel cereblon modulator for targeted protein degradation.

Sung Goo Park, Sunhong Kim, B. Park, 2019, European journal of medicinal chemistry.

Design and Synthesis of Novel Pyrazolo[3,4‐d]pyrimidin‐1‐yl piperidine Derivatives as Bruton's Tyrosine Kinase Inhibitors

Jeong Hee Jeon, Chi-Hoon Park, H. Jung, 2017 .

Modulation of osteocalcin expression by purmorphamine derivatives

Joong-Kook Choi, Joong-Kwon Choi, Yong-Min Kim, 2009, Genes & Genomics.

Discovery of quinolinone derivatives as potent FLT3 inhibitors.

Hyo-Jeong Lee, Sun-Young Han, Hye J. Chung, 2014, Biochemical and biophysical research communications.

Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors.

Suk-Kyeong Jung, D. Jeong, S. Ryu, 2006, Bioorganic & medicinal chemistry letters.

Novel 1,3-dipolar cycloadditions of fulvenes and hydrazonyl chlorides: a facile synthesis of the cyclopenta[d]pyridazines

Joong-Kwon Choi, E. Yum, S. Cho, 2009 .

Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.

N. Kang, H. Jung, Sun-Young Han, 2010, Bioorganic & medicinal chemistry letters.

Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.

H. Jung, Sun-Young Han, J. Ha, 2012, Bioorganic & medicinal chemistry letters.

Design and Synthesis of Novel 3-(2-Aminopyridin-3-yl)-1,2,4-Triazolo[4,3-b ]Pyridazine Derivatives as a Reversible Bruton's Tyrosine Kinase Inhibitors

Jeong Hee Jeon, Chi-Hoon Park, H. Jung, 2018, Bulletin of the Korean Chemical Society.

Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors

Byung Jin Byun, Eun-Young Kim, Chi-Hoon Park, 2016, Archives of pharmacal research.

Stereo- and regiocontrolled hydroxylation of oxyallyl [4+3] cycloadducts. A concise synthesis of hinokitiol

Jae Chol Lee, J. Cha, S. Cho, 1999 .

Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities

Chi-Hoon Park, H. Jung, C. Yun, 2014, Archives of pharmacal research.

Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment.

Chi-Hoon Park, H. Jung, C. Yun, 2013, Bioorganic & medicinal chemistry letters.

Reactivity of Acyl Derivatives toward Dialkoxytitanacyclopropane.

Robin K. Lammi, Jinhwa Lee, J. Cha, 1997, The Journal of organic chemistry.

On the stereochemistry of anion-accelerated [1,3]-sigmatropic rearrangement of 2-vinylcyclobutanols

J. Cha, S. Cho, Se Ho Kim, 2001 .

Enantioselective Synthesis of 2-Substituted Cyclobutanones.

J. Cha, S. Cho, 2000 .

On the mechanism of the anionic oxy-cope rearrangement of trans-1,2-dialkenylcyclobutanols.

J. Cha, P. Maurin, S. Cho, 2003, Angewandte Chemie.

Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitors.

Chi-Hoon Park, H. Jung, Sang-Un Choi, 2012, Bioorganic & medicinal chemistry letters.

PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives.

S. Han, H. Cheon, S. Rhee, 2006, Bioorganic & medicinal chemistry letters.

Scandium(III) Triflate—TMSCl Promoted Cyclization of Aziridin-1-yl Oximes to 5,6-Dihydro-4H-[1,2,4]oxadiazines.

J. Ahn, S. Kang, Joong-Kwon Choi, 2007 .

Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis

C. Ki, Jong-Won Kim, Young-Eun Kim, 2017, Orphanet Journal of Rare Diseases.

Scandium(III) triflate–TMSCl promoted cyclization of aziridin-1-yl oximes to 5,6-dihydro-4H-[1,2,4]oxadiazines

J. Ahn, S. Kang, Joong-Kwon Choi, 2006 .

Furo[3,2-h]quinoline Derivatives as a Gastric H + /K + -ATPase Inhibitors

H. Cheon, S. Kang, Sungsoo S. Kim, 2002 .

Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors

Chi-Hoon Park, H. Jung, C. Yun, 2016, Archives of Pharmacal Research.

Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors.

Eun-Young Kim, Chi-Hoon Park, H. Jung, 2014, Bioorganic & medicinal chemistry letters.

Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo

H. Jung, Mi-Ok Lee, H. Cha, 2012, Investigational New Drugs.

Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins.

H. Jeong, Chi-Hoon Park, H. Jung, 2015, Biochemical and biophysical research communications.

TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment

Yeonseok Chung, Y. Kim, Y. J. Choi, 2023, Journal for ImmunoTherapy of Cancer.

Design and Synthesis of Novel 2,4-Diamino-5-pyrazol-4-yl Pyrimidine Derivatives as Selective Tyro3 Kinase Inhibitors

Chang Hoon Lee, Joo-Youn Lee, S. Cho, 2018, Bulletin of the Korean Chemical Society.

Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance

K. Kang, J. Bae, Sung-Chul Lim, 2021, Cancer Research.

Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors.

N. Kang, H. Jung, Sang-Un Choi, 2011, Bioorganic & medicinal chemistry letters.

Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells

Hyung Rae Kim, Chi-Hoon Park, H. Jung, 2016, BMC Cancer.

Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R.

Sunjoo Ahn, Chi-Hoon Park, H. Jung, 2017, European journal of medicinal chemistry.

Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer

Y. Shin, Yoon-La Choi, N. Kim, 2020, Cancers.

Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects.

N. Kang, Sun-Young Han, G. Choi, 2013, International journal of oncology.

Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor

Sun‐mi Lee, Hyo-Jeong Lee, Yong‐Chul Kim, 2017, Oncology letters.

Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing bicyclic aminobenzazepines for anaplastic lymphoma kinase (ALK) inhibitor.

Sunjoo Ahn, Chi-Hoon Park, Minji Lee, 2015, Bioorganic & medicinal chemistry letters.

Suzuki reaction of cyclopenta[d][1,2]oxazine in aqueous solvent with water-soluble phosphine ligand

J. Ahn, S. Kang, Joong-Kwon Choi, 2006 .

Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors.

H. Seo, H. Jung, C. Yun, 2013, Bioorganic & medicinal chemistry letters.

Pyrazolo[3,4‐ d ]pyrimidine derivatives as irreversible Bruton's tyrosine kinase inhibitors

Chi-Hoon Park, Joo-Youn Lee, Heung Kyoung Lee, 2022, Bulletin of the Korean Chemical Society.

Design and Synthesis of 5‐Aryl ‐substituted Phenylpyrimidine‐2,4‐diamine Derivatives as Novel Mer and Tyro3 Kinase Inhibitors

D. Ryu, Joo-Youn Lee, S. Cho, 2020, Bulletin of the Korean Chemical Society.

Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities

Chi-Hoon Park, H. Jung, C. Yun, 2013, Archives of Pharmacal Research.

Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.

H. Jung, Sun-Young Han, J. Ha, 2012, Bioorganic & medicinal chemistry letters.

Protein Tyrosine Phosphatase 1B Inhibitors: Heterocyclic Carboxylic Acids

H. Cheon, J. Ahn, S. Kang, 2003 .

Diastereocontrol of [4 + 3] Cyclic Oxyallyl Cycloadditions by Alkoxy Substituents.

Jae Chol Lee, J. Cha, S. Cho, 1999, The Journal of organic chemistry.

Identification of osteogenic purmorphamine derivatives.

Joong-Kook Choi, H. Lee, Kyoung-Jin Park, 2008, Molecules and cells.

Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors.

Joo Yun Lee, Sunjoo Ahn, H. Jung, 2016, Bioorganic & medicinal chemistry.